Canton Mich. (April 13 2018) – MMS Holdings Inc. (MMS) – a global leading clinical research organization – announced today that it has surpassed a training milestone now with more than 700 training courses available in their learning management system.
This platform offers education to all MMS colleagues across North America Europe India and South Africa in a variety of formats from instructor led to self-directed sessions.
Each of the courses has been developed in-house and expertise in the data
sciences and clinical research arenas has led MMS to provide training outside of the organization to research sponsor teams as well. MMS staff provides training to sponsors on New Drug Application (NDA) submissions planning and best practices as well as clinical trial disclosure topics on a routine basis among other training.
“One of our most important assets is the people that work at MMS throughout the world with their data and science–first mindset and unmatched drive to meet our customer’s needs” said Michelle Gayari Head of Global Operations MMS. “From the onset MMS has been an organization focused on compliance and strength of process and a key component is supporting each colleague’s need to be continually learning and stretching within this fast-paced industry.”
To further this dedication to education and talent development within the research community and pharmaceutical and life sciences industries the company created MMS University to serve the continuing education needs of students recent graduates and current working professionals.